Provided by Tiger Fintech (Singapore) Pte. Ltd.

Monte Rosa Therapeutics

4.83
-0.0500-1.02%
Post-market: 4.830.00000.00%19:15 EDT
Volume:294.27K
Turnover:1.43M
Market Cap:297.09M
PE:62.33
High:4.94
Open:4.93
Low:4.78
Close:4.88
Loading ...
Jun 13, 2025

Major Issues Report

Form 8-K - Current report
May 08, 2025

Major Issues Report

Form 8-K - Current report
May 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 28, 2025

Correspondence

Form CORRESP - Correspondence
Mar 20, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 20, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 20, 2025

Major Issues Report

Form 8-K - Current report
Jan 10, 2025

Major Issues Report

Form 8-K - Current report
Dec 13, 2024

Major Issues Report

Form 8-K - Current report
Dec 05, 2024

Major Issues Report

Form 8-K - Current report
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Oct 30, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Oct 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 28, 2024

Major Issues Report

Form 8-K - Current report
Sep 24, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 12, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 12, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2024

Major Issues Report

Form 8-K - Current report